MiniMed CFO files initial Form 3 ownership

MiniMed Group, Inc. executive Chad Spooner, who serves as EVP and Chief Financial Officer, filed an initial statement of beneficial ownership on Form 3.

Rhea-AI Filing Summary

MiniMed Group, Inc. executive Chad Spooner, who serves as EVP and Chief Financial Officer, filed an initial statement of beneficial ownership on Form 3. The filing does not list any buy, sell, or other insider transactions and shows no derivative positions or holdings entries.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MiniMed Group (MMED) disclose in this Form 3 filing?

The Form 3 filing shows that Chad Spooner, EVP and Chief Financial Officer of MiniMed Group, Inc., has filed an initial statement of beneficial ownership. The report lists no insider transactions, no holdings entries, and no derivative positions at the time of filing.

Who is the reporting person in MiniMed Group (MMED)’s Form 3?

The reporting person is Chad Spooner, who serves as Executive Vice President and Chief Financial Officer of MiniMed Group, Inc. He is identified as an officer, not a director or ten percent owner, in this initial beneficial ownership statement.

Does the MiniMed Group (MMED) Form 3 show any insider share purchases or sales?

No insider share purchases or sales are reported in this Form 3. The transaction summary shows zero buy, sell, acquire, or dispose transactions, and net buy-sell direction is described as neutral with no recorded share activity.

Are there any derivative securities reported for MiniMed Group (MMED) in this Form 3?

No derivative securities are reported for Chad Spooner in this Form 3. The derivative summary is empty, exerciseCounts are zero, and derivative transaction counts are also zero, indicating no options, warrants, or similar instruments are listed here.

What does the net buy-sell direction indicate in MiniMed Group (MMED)’s Form 3?

The net buy-sell direction is labeled neutral with netBuySellShares at zero. This means the filing records no net insider buying or selling activity by Chad Spooner in connection with this initial beneficial ownership report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 06:14 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Spooner Chad

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.